HealthcareMedical DevicesNews

Global Epigenetics Market Outlook To 2026 By Thermo Fisher Scientific Inc.; Cellcentric; Syndax; New England Biolabs; Epizyme, Inc.; Domainex; Agilent Technologies & Others

Global epigenetics market is expected to register a healthy CAGR of 14.63% in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the significant advancements in technologies of epigenetics as well as rising investments and expenditure incurred to further develop the field of epigenetics.

The epigenetics market report studies wide-ranging evaluation of the market growth predictions and restrictions. Besides, epigenetics market analysis makes an assessment of the expected rise, growth or fall of the product in the specific forecast period. This report encompasses estimations of Compound Annual Growth Rate (CAGR) in % value for the forecasted period that will help client to take decision based on futuristic chart. The verified and advanced tools such as SWOT analysis and Porter’s Five Forces Analysis are used watchfully while structuring this epigenetics market research report. This market report helps unearth the general market conditions, existing trends and tendencies.

Get Sample Copy Of This Report @

Few of the major competitors currently working in the global epigenetics market are Illumina, Inc.; Merck KGaA; QIAGEN; F. Hoffmann-La Roche Ltd; Eisai Co., Ltd.; Novartis AG; Abcam plc; Diagenode s.a.; Active Motif; Zymo Research; Thermo Fisher Scientific Inc.; Cellcentric; Syndax; New England Biolabs; Epizyme, Inc.; Domainex; Agilent Technologies, Inc.; PerkinElmer Inc.; Bio-Rad Laboratories, Inc.; AsisChem Inc.; Enzo Life Sciences, Inc.; EpiGentek Group Inc.; BioVision Inc.; Bio-Techne; Promega Corporation; GeneTex, Inc. and Pacific Biosciences of California, Inc. among others.

Key Developments in the Market:

  • In May 2019, Souvien Therapeutics was established by Juvenescence, which will focus on development of innovative medicines for applications in neurodegenerative disorders with the help of targeting epigenetics in neurodegeneration. The company will focus on development of therapeutics to address the epigenetics mechanisms in neurodegenerations
  • In May 2018, Cellcentric announced that they had raised USD 26 million for the development of epigenetic based drug candidate for cancers till the stage of Phase 2B trials. The drug termed as, “CCS1477” has been evident to treat patients suffering from late-stage prostate cancer, being resistance against anti-androgen drugs. Cellcentric is aiming to increase its application of the drug candidate to more than just prostate cancer where the cancer is showing mutation signs of p300 and CBP proteins

Competitive Analysis:

Global epigenetics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of epigenetics market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Highlight points of the report:

1. CAGR values in the Global epigenetics market for the forecast period

2. Key trends in the market place

3.Global epigenetics market Major players and brands

4. Drivers and restrains of the market

5. Competitive landscape

6. Potential and niche segments/regions exhibiting promising growth

Get Detailed Table Of Content @

Segmentation: Global Epigenetics Market

By Product

  • Reagents
    • Antibody
    • Buffer
    • Histone
    • Magnetic Bead
    • Primer
    • Others
  • Kits & Assays
    • Bisulfite Conversion Kit
    • ChIP Sequencing Kit
    • Deep Sequencing Kit
    • Whole Genome Amplification Kit
    • RNA Sequencing Kit
    • Immunoprecipitation Kit
    • 5-HMC & 5-MC Analysis Kit
    • Methyltransferase Assays
    • Histone Assays
    • Others
  • Instruments
    • Mass Spectrometers
    • Next-Generation Sequencers (NGS)
    • Quantitative Polymerase Chain Reaction (qPCRs)
    • Sonicators
    • Others
  • Enzymes
    • DNA Modifying Enzyme
      • DNA Ligases
      • DNA Polymerases
      • Others
  • Protein Modifying Enzyme
    • Acetylases
    • Methyltransferases
    • Others
  • RNA Modifying Enzyme
    • Reverse Transcriptase
    • RNA Ligases
    • Others
  • Services
  • Bioinformatics Tools

By Technology

  • DNA Methylation
  • Histone Methylation
  • Histone Acetylation
  • Large Non-Coding RNA
  • MicroRNA Modification
  • Chromatin Structures

By Application

  • Oncology
    • Solid Tumors
    • Liquid Tumors
  • Non-Oncology
    • Inflammatory Diseases
    • Metabolic Diseases
    • Infectious Diseases
    • Cardiovascular Diseases
  • Developmental Biology
  • Drug Discovery
  • Others

By End-Users

  • Academic & Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organizations (CROs)

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East and Africa

Need more Information about Report Methodology @

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Data Bridge Market Research
Tel: +1-888-387-2818


Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *